Works matching DE "DACARBAZINE"

Results: 579

Primary leiomyosarcoma of the right ventricle with metastases in a young female.

Published in:

Polish Heart Journal / Kardiologia Polska, 2025, v. 83, n. 5, p. 647, doi. 10.33963/v.phj.104892

By:

Kwiatkowska, Ewa;
Jelonek, Michalina;
Kozioł, Mateusz;
Bartoszcze, Artur;
Drużbicki, Łukasz;
Mróz, Krystian;
Kapelak, Bogusław;
Legutko, Jacek;
Kleczyński, Paweł

Publication type:

Article

Acute toxic effects of single dose dacarbazine: hematological and histological changes in an animal model.

Published in:

Biotechnic & Histochemistry, 2014, v. 89, n. 8, p. 583, doi. 10.3109/10520295.2014.918653

By:

Milijašević, B;
Stefanović, D;
Lalić-Popović, M;
Tomić, Z;
Kolarović, J;
Lalošević, D;
Mikov, M

Publication type:

Article

Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. 77, doi. 10.1111/vco.12314

By:

Kezer, K. A.;
Barber, L. G.;
Jennings, S. H.

Publication type:

Article

Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 1, p. 25, doi. 10.1111/vco.12139

By:

Finotello, R.;
Stefanello, D.;
Zini, E.;
Marconato, L.

Publication type:

Article

Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells.

Published in:

BMC Complementary Medicine & Therapies, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12906-023-03933-w

By:

Pei, Junxia;
Su, Zhou;
Zeng, Xin;
Zhong, Ya;
Zhang, Yamei;
Yang, Yixi;
Lu, Qiuxia;
Li, Jian;
Deng, Yu

Publication type:

Article

Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma.

Published in:

NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00684-w

By:

Phillipps, Jordan;
Nassief, George;
Morecroft, Renee;
Adeyelu, Tolulope;
Elliott, Andrew;
Abdulla, Farah;
Vanderwalde, Ari;
Park, Soo;
Butt, Omar;
Zhou, Alice;
Ansstas, George

Publication type:

Article

Rat tissue responses to dacarbazine-containing implants made of cross-linked polyurethane of different densities.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2022, n. 4, p. 40, doi. 10.31288/oftalmolzh202244048

By:

Galatenko, N. A.;
Rozhnova, R. A.;
Kuliesh, D. V.;
Denisenko, V. D.;
Maletskyy, A. P.;
Bigun, N. M.

Publication type:

Article

MRI-guided photothermal/photodynamic immune activation combined with PD-1 inhibitor for the multimodal combination therapy of melanoma and metastases.

Published in:

Regenerative Biomaterials, 2024, v. 11, p. 1, doi. 10.1093/rb/rbae019

By:

Wu, Changqiang;
Chen, Wei;
Yan, Shuang;
Zhong, Jie;
Du, Liang;
Yang, Chenwu;
Pu, Yu;
Li, Yang;
Lin, Jiafu;
Zeng, Mei;
Zhang, Xiaoming

Publication type:

Article

Analisi di costo-efficacia di brentuximab vedotin in combinazione con doxorubicina, vinblastina e dacarbazina (AVD) in pazienti adulti affetti da linfoma di Hodgkin in stadio IV.

Published in:

Global & Regional Health Technology Assessment, 2024, v. 11, n. 1, p. 248, doi. 10.33393/grhta.2024.3167

By:

Marcellusi, Andrea;
Bini, Chiara;
Mennini, Francesco Saverio;
Ripoli, Silvia;
Fioravanti, Laura;
Paly, Victoria Federico;
Molinari, Alexa Lina;
Morelli, Paolo;
Krotneva, Stanimira;
Shujun Li

Publication type:

Article

Experimental Models for Rare Melanoma Research—The Niche That Needs to Be Addressed.

Published in:

Bioengineering (Basel), 2023, v. 10, n. 6, p. 673, doi. 10.3390/bioengineering10060673

By:

Ionita, Ioana;
Malita, Daniel;
Dehelean, Cristina;
Olteanu, Emilian;
Marcovici, Iasmina;
Geamantan, Andreea;
Chiriac, Sorin;
Roman, Andrea;
Radu, Daniela

Publication type:

Article

Selected Flavonoids to Target Melanoma: A Perspective in Nanoengineering Delivery Systems.

Published in:

Bioengineering (Basel), 2022, v. 9, n. 7, p. 290, doi. 10.3390/bioengineering9070290

By:

Coutinho, Tiago E.;
Souto, Eliana B.;
Silva, Amélia M.

Publication type:

Article

THE INCREASE IN THE PHOTODYNAMIC POTENTIAL OF DACARBAZINE AS A RESULT OF PH DEPENDENCE.

Published in:

Lucrari Stiintifice: Seria Medicina Veterinara, 2021, v. 64, n. 2, p. 23

By:

COMAN, Ana-Maria;
FUMĂREL, Radu;
BUDAŞCU, Valentin;
ALEXANDRU, Diana Mihaela

Publication type:

Article

Anti-proliferation of Melanoma Cells and Immune Stimulation by the Cyanobacterial Indole-alkaloid Scytonemin.

Published in:

Fine Focus, 2021, v. 7, n. 1, p. 54, doi. 10.33043/ff.7.1.54-63

By:

Evans, Jadon;
Jones, Aaron;
Blumenthal, Elliott;
Soule, Tanya

Publication type:

Article

Assessment of Photo-Induced Cytotoxic Activity of Cachrys sicula and Cachrys libanotis Enriched-Coumarin Extracts against Human Melanoma Cells.

Published in:

Plants (2223-7747), 2021, v. 10, n. 1, p. 123, doi. 10.3390/plants10010123

By:

Marrelli, Mariangela;
Perri, Maria Rosaria;
Amodeo, Valentina;
Giordano, Francesca;
Statti, Giancarlo A.;
Panno, Maria Luisa;
Conforti, Filomena

Publication type:

Article

Synergistic inhibitory effects of the oxyresveratrol and dacarbazine combination against melanoma cells.

Published in:

Oncology Letters, 2021, v. 22, n. 3, p. N.PAG, doi. 10.3892/ol.2021.12928

By:

Lee, Sang Gyu;
Lee, Dong Gun;
Joo, Yong Hoon;
Chung, Namhyun

Publication type:

Article

Capsaicin induces apoptosis and autophagy in human melanoma cells.

Published in:

Oncology Letters, 2019, v. 17, n. 6, p. 4827

By:

Chu, Haihan;
Li, Meng;
Wang, Xiuchun

Publication type:

Article

Combined pitavastatin and dacarbazine treatment activates apoptosis and autophagy resulting in synergistic cytotoxicity in melanoma cells.

Published in:

Oncology Letters, 2017, v. 14, n. 6, p. 7993, doi. 10.3892/ol.2017.7189

By:

Al-Qatati, Abeer;
Aliwaini, Saeb

Publication type:

Article

Long-term survival of a patient with scalp angiosarcoma and multiple metastases treated using combination therapy: A case report.

Published in:

Oncology Letters, 2015, v. 9, n. 4, p. 1725, doi. 10.3892/ol.2015.2919

By:

JUN YE;
XIAO-FEN LI;
YONG-DONG WANG;
YING YUAN

Publication type:

Article

Primary adrenal nodular lymphocyte-predominant Hodgkin lymphoma: A case report and review of the literature.

Published in:

2014

By:

JINGJING WANG;
JIN'AN MA;
CHUNHONG HU;
DAIQIANG LI;
XIAOLING SHE

Publication type:

Case Study

Effect of carboplatin when administered after dacarbazine failure: Clinical benefit of sequential therapy.

Published in:

Molecular & Clinical Oncology, 2020, v. 13, n. 6, p. N.PAG, doi. 10.3892/mco.2020.2144

By:

Merry, Eve;
Marples, Maria;
Danson, Sarah;
Harding, David;
Denny, James;
Vazquez, Ignacio;
Chesshire, Louise;
Taylor, Fiona;
Fusi, Alberto;
Dalgleish, Angus G.

Publication type:

Article

Possible Influence of Weight Gain and Creatinine Levels in Predicting Response to Nivolumab: A Multicenter Analysis.

Published in:

Metabolites (2218-1989), 2020, v. 10, n. 12, p. 510, doi. 10.3390/metabo10120510

By:

Nitipir, Cornelia;
Orlov-Slavu, Cristina;
Alecu, Lucian;
Slavu, Iulian;
Pantea-Stoian, Anca;
Celmare, Ionela Daniela;
Olaru, Mihaela;
Calu, Valentin;
Suceveanu, Andra-Iulia;
Mazilu, Laura;
Gheorghe, Andreea-Daniela;
Gheorghe, Adelina Silviana;
Poiana, Catalina;
Hainarosie, Razvan;
Ionescu, Sanziana Octavia;
Stanculeanu, Dana Lucia

Publication type:

Article

Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.558894

By:

Wong, Ho Ning;
Lewies, Angélique;
Haigh, Michaela;
Viljoen, Joe M.;
Wentzel, Johannes F.;
Haynes, Richard K.;
du Plessis, Lissinda H.

Publication type:

Article

Preparation and Characterization of Chitosan Nanoparticles for Chemotherapy of Melanoma Through Enhancing Tumor Penetration.

Published in:

Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00317

By:

Guo, Hui;
Li, Faping;
Qiu, Heping;
Liu, Jianhua;
Qin, Sihao;
Hou, Yuchuan;
Wang, Chunxi

Publication type:

Article

Utilization of solid in oil nanodispersion to prepare a topical vemurafenib as potential delivery system for skin melanoma.

Published in:

Applied Nanoscience, 2023, v. 13, n. 4, p. 2845, doi. 10.1007/s13204-021-02158-y

By:

Almajidi, Yasir Q.;
Maraie, Nidhal K.;
Raauf, Ayad M. R.

Publication type:

Article

Adjuvant therapy with low-dose interferon-beta for stage II and III melanoma: results of a retrospective analysis.

Published in:

Clinical & Experimental Dermatology, 2017, v. 42, n. 7, p. 781, doi. 10.1111/ced.13179

By:

Yanagi, T.;
Hata, H.;
Homma, E.;
Kitamura, S.;
Imafuku, K.;
Shimizu, H.

Publication type:

Article

Histone Deacetylases (HDAC) Inhibitor—Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor.

Published in:

Genes, 2023, v. 14, n. 6, p. 1295, doi. 10.3390/genes14061295

By:

Drzewiecka, Małgorzata;
Gajos-Michniewicz, Anna;
Hoser, Grażyna;
Jaśniak, Dominika;
Barszczewska-Pietraszek, Gabriela;
Sitarek, Przemysław;
Czarny, Piotr;
Piekarski, Janusz;
Radek, Maciej;
Czyż, Małgorzata;
Skorski, Tomasz;
Śliwiński, Tomasz

Publication type:

Article

Whole Body Microwave Irradiation for Improved Dacarbazine Therapeutical Action in Cutaneous Melanoma Mouse Model.

Published in:

Radiology Research & Practice, 2013, p. 1, doi. 10.1155/2013/414816

By:

Neagu, Monica;
Constantin, Carolina;
Martin, Diana;
Albulescu, Lucian;
Iacob, Nicusor;
Ighigeanu, Daniel

Publication type:

Article

Targeted Therapies Compared to Dacarbazine for Treatment of BRAF<sup>V600E</sup> Metastatic Melanoma: A Cost-Effectiveness Analysis.

Published in:

Journal of Skin Cancer, 2015, v. 2015, p. 1, doi. 10.1155/2015/505302

By:

Shih, Vanessa;
ten Ham, Renske M.;
Bui, Christine T.;
Tran, Dan N.;
Ting, Jie;
Wilson, Leslie

Publication type:

Article

Immunochemotherapy - A Missed Opportunity for Metastasized Malignant Melanoma? Reporting a Therapeutic Success with Checkpoint Inhibitor Rechallenge after Cytotoxic Immuno-Priming in a Heavily Pretreated Patient.

Published in:

2022

By:

Kiderlen, Til R.;
Delmastro, Nicola;
Jobst, Friedemann;
de Wit, Maike

Publication type:

Case Study

Nivolumab in the treatment of malignant melanoma: review of the literature.

Published in:

OncoTargets & Therapy, 2015, v. 8, p. 2045, doi. 10.2147/OTT.S62102

By:

Mashima, Emi;
Inoue, Akiha;
Sakuragi, Yumiko;
Yamaguchi, Takashi;
Sasaki, Natsuko;
Hara, Yoko;
Omoto, Daisuke;
Ohmori, Shun;
Haruyama, Sanehito;
Sawada, Yu;
Yoshioka, Manabu;
Nishio, Daisuke;
Nakamura, Motonobu

Publication type:

Article

La cirugía en melanoma cutáneo maligno y las nuevas drogas.

Published in:

Cirugía y Cirujanos, 2015, v. 83, n. 2, p. 175, doi. 10.1016/j.circir.2015.04.016

By:

Nieweg, Omgo E.;
Gallegos-Hernández, José Francisco

Publication type:

Article

PERSONALISED THERAPY FOR MELANOMA.

Published in:

Rad Hrvatske Akademije Znanosti i Umjetnosti. Medicinske Znanosti, 2014, v. 520, n. 40, p. 51

By:

Broziĉ, Jasmina Mariĉ;
Ðakoviĉ, Nikola

Publication type:

Article

FILM-FORMING COMPOSITIONS BASED ON POLYURETHANEUREAS WITH EXTENDED RELEASE OF DACARBAZINE.

Published in:

Polymer Journal / Polymernyi Zhurnal (18181724), 2023, v. 45, n. 4, p. 319, doi. 10.15407/polymerj.45.04.319

By:

Prymushko, S. O.;
Galatenko, N. A.;
Rozhnova, R. A.;
Kozlova, G. A.;
Gladyr, I. I.;
Nechaeva, L. Yu.

Publication type:

Article

РОЗРОБКА ТА ДОСЛІДЖЕННЯ КОМПОЗИЦІЙНИХ МАТЕРІАЛІВ З ДАКАРБАЗИНОМ МЕДИЧНОГО ПРИЗНАЧЕННЯ НА ОСНОВІ ПІНОПОЛІУРЕТАНСЕЧОВИН

Published in:

Polymer Journal / Polymernyi Zhurnal (18181724), 2022, v. 44, n. 3, p. 222, doi. 10.15407/polymerj.44.03.222

By:

ДЕНИСЕНКО, В. Д.;
ГАЛАТЕНКО, Н. А.;
РОЖНОВА, Р. А.;
НЕЧАЄВА, Л. Ю.

Publication type:

Article

Synthesis of Arylmethylene-bis(3-hydroxy-5,5-dimethylcyclohex-2-en-1-one) Derivatives and Their Effect on Tyrosinase Activity.

Published in:

Croatica Chemica Acta, 2021, v. 94, n. 3, p. 139, doi. 10.5562/cca3857

By:

Veljović, Elma;
Rimac, Hrvoje;
Salihović, Mirsada;
Špirtović-Halilović, Selma;
Osmanović, Amar;
Kovač, Nejra;
Kiršek, Elizabeta;
Članjak-Kudra, Enida;
Špirtović, Dijana;
Bojić, Mirza

Publication type:

Article

Tracking the Evolution of Cutaneous Melanoma by Multiparameter Flow Sorting and Genomic Profiling.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1758, doi. 10.3390/ijms26041758

By:

Roma, Luca;
Lorber, Thomas;
Rau, Sabrina;
Barrett, Michael T.;
Ercan, Caner;
Panebianco, Federica;
Piscuoglio, Salvatore;
Glatz, Katharina;
Bubendorf, Lukas;
Ruiz, Christian

Publication type:

Article

Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma.

Published in:

2025

By:

Martínez-Vila, Clara;
Teixido, Cristina;
Aya, Francisco;
Martín, Roberto;
González-Navarro, Europa Azucena;
Alos, Llucia;
Castrejon, Natalia;
Arance, Ana

Publication type:

Literature Review

Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong.

Published in:

Cost Effectiveness & Resource Allocation, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12962-020-0200-9

By:

Loong, Herbert H.;
Wong, Carlos K. H.;
Leung, Linda K. S.;
Tan, S. C.;
Jen, Jason;
Lee, Mary Y. K.;
Aguiar-Ibáñez, Raquel;
Wang, Jingshu

Publication type:

Article

Elevated lactate dehydrogenase in adjuvant BRAF and MEK inhibitor therapy does not have diagnostic significance in detecting melanoma recurrence.

Published in:

Contemporary Oncology / Współczesna Onkologia, 2025, v. 29, n. 1, p. 107, doi. 10.5114/wo.2025.149038

By:

Galus, Łukasz;
Tusień-Małecka, Daria;
Mackiewicz, Jacek

Publication type:

Article

First-in-human phase I dose-escalation and dose-expansion trial of the selective MEK inhibitor HL-085 in patients with advanced melanoma harboring NRAS mutations.

Published in:

BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-022-02669-7

By:

Wang, Xuan;
Luo, Zhiguo;
Chen, Jing;
Chen, Yu;
Ji, Dongmei;
Fan, Li;
Chen, Ling;
Zhao, Qian;
Hu, Pei;
Sun, Peng;
Jia, Zhongwei;
Guo, Jun;
Si, Lu

Publication type:

Article

Study design and rationale for a randomised, placebo-controlled, doubleblind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT).

Published in:

BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1470-z

By:

Carvajal, Richard D.;
Schwartz, Gary K.;
Mann, Helen;
Smith, Ian;
Nathan, Paul D.

Publication type:

Article

A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.

Published in:

BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-561

By:

Halperin, Daniel M.;
Phan, Alexandria T.;
Hoff, Ana O.;
Aaron, Marie;
Yao, James C.;
Hoff, Paulo M.

Publication type:

Article

Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma.

Published in:

BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-423

By:

Klinac, Dragana;
Gray, Elin S.;
Freeman, James B.;
Reid, Anna;
Bowyer, Samantha;
Millward, Michael;
Ziman, Melanie

Publication type:

Article

Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide.

Published in:

2014

By:

Tentori, Lucio;
Ricci-Vitiani, Lucia;
Muzi, Alessia;
Ciccarone, Fabio;
Pelacchi, Federica;
Calabrese, Roberta;
Runci, Daniele;
Pallini, Roberto;
Caiafa, Paola;
Graziani, Grazia

Publication type:

journal article

Chemotherapy for Soft-Tissue Sarcomas.

Published in:

Oncology (08909091), 2015, v. 29, n. 1, p. 43

By:

RAVI, VINOD;
PATEL, SHREYASKUMAR;
BENJAMIN, ROBERT S.

Publication type:

Article

CTLA-4 Antibodies: New Directions, New Combinations.

Published in:

Oncology (08909091), 2014, p. 1

By:

Funt, Samuel A.;
Page, David B.;
Wolchok, Jedd D.;
Postow, Michael A.

Publication type:

Article

Lysophosphatidic acid receptor-2 (LPA2)-mediated signaling enhances chemoresistance in melanoma cells treated with anticancer drugs.

Published in:

Molecular & Cellular Biochemistry, 2020, v. 469, n. 1/2, p. 89, doi. 10.1007/s11010-020-03730-w

By:

Minami, Kanako;
Ueda, Nanami;
Ishimoto, Kaichi;
Tsujiuchi, Toshifumi

Publication type:

Article

Replacing procarbazine with dacarbazine in escalated BEACOPP reduces clinical toxicity with no loss of efficacy yet protects stem cells from excess somatic mutational damage.

Published in:

Hematological Oncology, 2023, v. 41, p. 356, doi. 10.1002/hon.3164_256

By:

Santarsieri, A.;
Mitchell, E.;
Sanghvi, R.;
Lee‐Six, H.;
Sturgess, K.;
Brice, P.;
Menne, T.;
Osborne, W.;
Creasey, T.;
Ardesnhna, K. M.;
Behan, S.;
Bhuller, K.;
Booth, S.;
Chavda, N. D.;
Collins, G.;
Culligan, D.;
Cwynarski, K.;
Davies, A.;
Downing, A.;
Dutton, D.

Publication type:

Article

Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for early‐stage classical Hodgkin Lymphoma: Updated results from an ongoing phase 2 study (SGN35‐027 Part C).

Published in:

Hematological Oncology, 2023, v. 41, p. 353, doi. 10.1002/hon.3164_254

By:

Abramson, J. S.;
Straus, D.;
Bartlett, N.;
Burke, J. M.;
Lynch, R. C.;
Domingo‐Domenech, E.;
Hess, B.;
Schuster, S.;
Linhares, Y.;
Ramchandren, R.;
Gandhi, M.;
Mowat, R.;
Shah, H.;
Jurczak, W.;
Re, A.;
Hahn, U.;
Prince, H. M.;
Ho, L.;
Guo, W.;
Jain, S.

Publication type:

Article

PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblastine, and Dacarbazine for Newly Diagnosed Stage III or IV Hodgkin Lymphoma.

Published in:

Hematological Oncology, 2023, v. 41, p. 351, doi. 10.1002/hon.3164_253

By:

Moskowitz, A.;
Savage, K.;
Feldman, T.;
Ganesan, N.;
Hancock, H.;
Davey, T.;
Perez, L.;
Santarosa, A.;
Subzwari, S.;
Capadona, C.;
Yang, C.;
Galasso, N.;
David, K.;
Epstein‐Peterson, Z.;
Khan, N.;
Kumar, A.;
Hamlin, P.;
Ghione, P.;
Lue, J.;
Straus, D.

Publication type:

Article